Navigation Links
Zansors Announces Issued Patent Protecting Adhesive for Wearable Health Sensors

Zansors announced today its first utility patent for a wearable patch comprising multiple separable adhesive layers, as issued by the U.S. Patent & Trademark Office (USPTO). The patent covers a wearable patch with stackable adhesive layers as it applies to combining electronics and health monitoring. This invention will be critical to the future of wearable tech for health applications.

Zansors is committed to putting affordable medical-grade tools into the hands of consumers, thus responding to the demand for Personal Health Analytics, as the market moves beyond entry-level devices.

The patented invention allows for peel-and-stick sensor patches comprising of hardware electronics components, durable components, integrated circuits, and disposable layers. Zansors engineering and innovation team pioneered a method to reuse hardware electronics, reduce hardware waste and increase power and storage via the use of more robustly engineered components.

The utility patent will be commercialized for many applications including sleep apnea, stroke, glucose monitors, and next-generation adhesive sensors. In addition, the patent has positive implications for global health by making wearable sensors more affordable. These factors underpin the path to commercialization for Zansors’ R&D investments.

“Wearable health sensors have the potential to save lives, but only when they are supported by new and novel technologies that foster medical-grade accuracy and ease-of-use. At Zansors, we are pioneering the inventions that will be commercialized for a global audience,” said Abhijit Dasgupta, Ph.D., Co-Founder and Chief Data Science Officer at Zansors. “Our first issued utility patent is going to pave the way for next-generation medical technologies, and our team of engineers, data scientists, information architects and designers are continuing to work together to create additional tools and secure additional patents.”

The patent on this technology is critical to supporting Zansors’ goal to provide personal health analytics tech wearables that are accessible and affordable to consumers. Zansors plans to commercialize this invention, in conjunction with additional new technologies that are patent-pending.

“We’re preparing for the future of wearable health technology,” said Baabi Das, Co-Founder. “Making wearables that are easy to use, high quality and affordable will be key on the path to making them a seamless part of life. Zansors development of an adhesive you can use again and again, without losing the quality of data you collect, is a huge step in that direction.”

Global law firm DLA Piper’s Reston, Va. location supported patent prosecution. For more information on this patent, view the summary at Learn more about Zansors’ technologies at

About Zansors
Zansors is a Washington, DC metro-based healthcare innovation company delivering Personal Healthcare Analytics into the hands of consumers via wearable bio-sensors and health apps. Driven by our credo of “know yourself,” Zansors combines evidence-based apps, bioengineering and data analytics, allowing consumers to take charge of their health. Our proprietary biotechnology platform includes micro-sensors and micro-fluidics (also known as “lab-on-a-chip”) backed by a strong portfolio of patents filed. Zansors has previously received 6 funding awards by NIH and has formal partnerships with the University of Michigan and George Washington University.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Zansors Wins NIH Grant to Advance Wearable At-Home Affordable Sleep Apnea Detection
2. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
3. Annual Conference about Technology Solutions for People with Disabilities Announces Program
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. Verenium Announces Preliminary Financial Results For Fiscal 2012
6. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
7. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
8. EAG Announces New General Manager of Release-To-Production (RTP) Division
9. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
10. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
11. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
Post Your Comments:
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers ... result, food and beverage products rely on these ingredients to create stable quality ... label declarations. This paradigm shift triggers food formulators to seek out alternatives for ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
(Date:5/2/2019)... RAPID CITY, S.D. (PRWEB) , ... April 30, 2019 , ... ... of society, from industrial scale macro breweries to local craft breweries, and even home ... scale, involves very complex chemical and biological processes, that when mastered can produce a ...
(Date:4/25/2019)... , ... April 23, 2019 , ... Frank is an albino, deaf Great Dane. His ... want him due to his health issues. Despite his hearing impairment, he was always an ... the two would play all day, every day. As the two grew, playtime became rougher ...
Breaking Biology Technology:
(Date:6/13/2019)... HORSHAM, Pa. (PRWEB) , ... June 13, 2019 ... ... Ancillare, LP , the first organization exclusively serving the end-to-end clinical and ancillary ... companies, as well as contract and medical research organizations, today announced it will ...
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... Improved Pharma ... the July 2019 issue of AAPS PharmSciTech. The article was published online on April ... of Improved Pharma, along with Xiaoming Sean Chen of Purdue University. , The article ...
(Date:6/6/2019)... ... 2019 , ... Pelican BioThermal , the global name ... center in Mexico City, Mexico. Mexico is the second largest pharmaceutical market in ... billion in pharmaceutical exports since 2015. The Mexico City network station will service, ...
Breaking Biology News(10 mins):